Adoption of Triple Combination Therapy Accelerates at Unprecedented Rates as Precision Medicine Revolution ContinuesRockville, MD, Jan. 29, 2025 (GLOBE NEWSWIRE) -- According to Fact.MR, a market ...

The fixed-dose triple-combination therapy, dubbed ‘vanza triple’, is set to build on the success of Vertex’s top-selling combination of elexacaftor, tezacaftor and ivacaftor (Trikafta ...

A multicenter collaboration has identified a potential new treatment for an aggressive sarcoma arising in the nerves. The ...

have found a new potential combination therapy to combat antimicrobial resistance (AMR) by targeting two key bacterial enzymes involved in resistance. The study, "The Triple Combination of ...

Patients with metastatic colorectal cancer (mCRC) harboring BRAF V600E mutations benefitted from first-line treatment with the targeted therapies encorafenib and cetuximab plus a mFOLFOX6 chemotherapy ...

European regulators have accepted Novartis’ filing for a triple combination therapy for asthma known as QVM149, triggering payments to development partners Vectura and Sosei. QVM149 is a triple ...

Combining immunotherapy and radiation may help treat triple-negative breast cancer ... into those that would likely benefit from the combination therapy,” says Simon Knott, PhD , a codirector ...

The combination of an inhaled corticosteroid ... Trelegy also has a COPD triple therapy competitor approved in Europe, where Chiesi was first to market earlier this year with Trimbow.

if I see one of these patients next week I'm going to treat them with encorafenib, cetuximab, and FOLFOX as first-line therapy ... bevacizumab (n=243) Triple combination: EC-FOLFOX6 (n=236 ...

John Friend, MD, CEO of Kazia Therapeutics added, "The novelty of the science that Professor Rao has proposed with this dual ...